首页> 外文期刊>American journal of medical genetics, Part A >Atypical fibrodysplasia ossificans progressiva diagnosed by whole-exome sequencing
【24h】

Atypical fibrodysplasia ossificans progressiva diagnosed by whole-exome sequencing

机译:全外显子测序诊断为非典型性骨增生性纤维增生

获取原文
获取原文并翻译 | 示例
           

摘要

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by congenital malformations of the great toes and progressive heterotopic ossification of connective tissue that begins during the first decade of life. Our patient presented with intrauterine growth retardation, respiratory distress, neonatal onset soft tissue masses, bilateral hallux valgus, and congenital anomalies of the thyroid and uterus. She was initially diagnosed with atypical infantile myofibromatosis based on clinical and pathological findings. She underwent whole-exome sequencing (WES) as part of the FORGE study to identify the gene for infantile myofibromatosis; however a de novo dominant mutation in ACVR1 (NM_001105.4:c.617G>A) revised the diagnosis to FOP. This patient highlights the utility of WES as an early diagnostic tool in the investigation of patients with unusual presentations of rare diseases, thereby providing clinicians with accurate molecular diagnoses and the opportunity to tailor clinical management to improve patient care. (c) 2015 Wiley Periodicals, Inc.
机译:骨化性纤维增生症(FOP)是一种罕见的遗传疾病,其特征是先天性大脚趾畸形和结缔组织的渐进性异位骨化从生命的前十年开始。本例患者出现宫内发育迟缓,呼吸窘迫,新生儿发作的软组织肿块,双侧拇外翻以及甲状腺和子宫的先天性异常。根据临床和病理结果,她最初被诊断出患有非典型的婴儿肌纤维瘤病。作为FORGE研究的一部分,她接受了全外显子测序(WES),以鉴定婴儿肌纤维瘤病的基因。然而,ACVR1的从头显性突变(NM_001105.4:c.617G> A)将诊断修改为FOP。该患者强调了WES作为早期诊断工具在调查罕见疾病罕见表现的患者中的效用,从而为临床医生提供了准确的分子诊断,并为临床管理提供了机会来改善患者护理。 (c)2015年威利期刊有限公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号